Published in Proc Natl Acad Sci U S A on November 25, 2002
Nitric oxide induces CD4+CD25+ Foxp3 regulatory T cells from CD4+CD25 T cells via p53, IL-2, and OX40. Proc Natl Acad Sci U S A (2007) 1.45
Nitric oxide is a key component in inflammation-accelerated tumorigenesis. Cancer Res (2008) 1.19
Regulation of type 17 helper T-cell function by nitric oxide during inflammation. Proc Natl Acad Sci U S A (2011) 1.14
Central role of nitric oxide in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus. Arthritis Res Ther (2010) 1.05
Suppression of regulatory T cells by IL-12p40 homodimer via nitric oxide. J Immunol (2009) 1.01
Induction and stability of human Th17 cells require endogenous NOS2 and cGMP-dependent NO signaling. J Exp Med (2013) 0.99
Spotlights on immunological effects of reactive nitrogen species: When inflammation says nitric oxide. World J Exp Med (2015) 0.97
Induction of inducible NO synthase in bystander human T cells increases allogeneic responses in the vasculature. Proc Natl Acad Sci U S A (2007) 0.95
Nitric oxide as an endogenous mutagen for Sendai virus without antiviral activity. J Virol (2004) 0.92
Nitric oxide-induced regulatory T cells inhibit Th17 but not Th1 cell differentiation and function. J Immunol (2013) 0.91
Outer membrane protein A (OmpA) of Shigella flexneri 2a links innate and adaptive immunity in a TLR2-dependent manner and involvement of IL-12 and nitric oxide. J Biol Chem (2012) 0.90
TNF-alpha antagonism generates a population of antigen-specific CD4+CD25+ T cells that inhibit protective immunity in murine histoplasmosis. J Immunol (2008) 0.90
Effects of CXCL10 on dendritic cell and CD4+ T-cell functions during Leishmania amazonensis infection. Infect Immun (2007) 0.90
Role of increased guanosine triphosphate cyclohydrolase-1 expression and tetrahydrobiopterin levels upon T cell activation. J Biol Chem (2011) 0.88
Nitric oxide modulates TGF-beta-directive signals to suppress Foxp3+ regulatory T cell differentiation and potentiate Th1 development. J Immunol (2011) 0.87
Arginine depletion increases susceptibility to serious infections in preterm newborns. Pediatr Res (2014) 0.85
Nitric oxide enhances Th9 cell differentiation and airway inflammation. Nat Commun (2014) 0.85
Nitrosothiols in the immune system: signaling and protection. Antioxid Redox Signal (2012) 0.84
Link between cancer and Alzheimer disease via oxidative stress induced by nitric oxide-dependent mitochondrial DNA overproliferation and deletion. Oxid Med Cell Longev (2013) 0.84
Nitric oxide inhibits the accumulation of CD4+CD44hiTbet+CD69lo T cells in mycobacterial infection. Eur J Immunol (2012) 0.84
Evaluation of serum nitric oxide level in patients with oral lichen planus. J Dent (Shiraz) (2014) 0.84
Plasticity within the αβ⁺CD4⁺ T-cell lineage: when, how and what for? Open Biol (2013) 0.83
Generation of NO by bystander human CD8 T cells augments allogeneic responses by inhibiting cytokine deprivation-induced cell death. Am J Transplant (2009) 0.81
NOS Inhibition Modulates Immune Polarization and Improves Radiation-Induced Tumor Growth Delay. Cancer Res (2015) 0.81
TNF-α and CD8+ T cells mediate the beneficial effects of nitric oxide synthase-2 deficiency in pulmonary paracoccidioidomycosis. PLoS Negl Trop Dis (2013) 0.80
Indispensable roles of OX40L-derived signal and epistatic genetic effect in immune-mediated pathogenesis of spontaneous pulmonary hypertension. BMC Immunol (2011) 0.80
Immunosuppression: cause for failures of vaccines against African Trypanosomiases. PLoS Negl Trop Dis (2013) 0.80
CXCL12 induction of inducible nitric oxide synthase in human CD8 T cells. J Heart Lung Transplant (2008) 0.78
Thiopurine Prodrugs Mediate Immunosuppressive Effects by Interfering with Rac1 Protein Function. J Biol Chem (2016) 0.77
Comparative studies on the roles of mediator molecules in expression of the suppressor activity of Mycobacterium avium complex-induced immunosuppressive macrophages against T cell and B cell mitogenic responses. Clin Exp Immunol (2006) 0.76
OGR1/GPR68 Modulates the Severity of Experimental Autoimmune Encephalomyelitis and Regulates Nitric Oxide Production by Macrophages. PLoS One (2016) 0.75
Role of nitric oxide in the regulation of immune responses during rabies virus infection in mice. Virusdisease (2016) 0.75
Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev (1991) 42.38
TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol (1989) 31.72
Functional diversity of helper T lymphocytes. Nature (1996) 18.09
Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Science (1990) 12.13
Nitric oxide and the immune response. Nat Immunol (2001) 10.00
Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol (1994) 8.43
Nitric oxide synthases: roles, tolls, and controls. Cell (1994) 8.36
Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med (1998) 7.24
Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol (1991) 6.92
B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell (1995) 6.88
Altered immune responses in mice lacking inducible nitric oxide synthase. Nature (1995) 6.20
Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu Rev Immunol (1992) 4.92
Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J Exp Med (1995) 4.12
Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells. J Exp Med (1995) 3.98
Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells. J Exp Med (2001) 3.75
IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB. Immunity (1997) 3.60
Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med (1998) 3.53
Signaling and transcription in T helper development. Annu Rev Immunol (2000) 3.44
"NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Methods Enzymol (1996) 3.34
Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr Opin Immunol (2000) 3.14
A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc Natl Acad Sci U S A (1996) 3.07
The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. Immunity (2000) 2.70
Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells. J Exp Med (1998) 2.40
The role of TH1 and TH2 cells in a rodent malaria infection. Science (1993) 2.38
Nonspecific defence mechanism: the role of nitric oxide. Immunol Today (1991) 2.37
IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J Immunol (1997) 2.29
The effect of nitric oxide on cell respiration: A key to understanding its role in cell survival or death. Proc Natl Acad Sci U S A (2000) 1.96
Expression cloning of a human IL-12 receptor component. A new member of the cytokine receptor superfamily with strong homology to gp130. J Immunol (1994) 1.84
Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophages. Eur J Immunol (1991) 1.84
Nitric oxide and virus infection. Immunology (2000) 1.78
Nitric oxide and bone. Immunology (2001) 1.60
Biphasic regulation of NF-kappa B activity underlies the pro- and anti-inflammatory actions of nitric oxide. J Immunol (2001) 1.58
Mechanism of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages. J Leukoc Biol (1994) 1.45
Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages. Eur J Immunol (1998) 1.42
T(H)1 and T(H)2 cells: a historical perspective. Nat Rev Immunol (2002) 1.40
Regulation of lymphocyte functions by nitric oxide. Curr Opin Immunol (1995) 1.35
IL-12 receptor. I. Characterization of the receptor on phytohemagglutinin-activated human lymphoblasts. J Immunol (1992) 1.32
Effects of nitric oxide on the induction and differentiation of Th1 cells. Eur J Immunol (1999) 1.23
Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator? Immunol Today (1998) 1.19
Mice lacking inducible nitric-oxide synthase are more susceptible to herpes simplex virus infection despite enhanced Th1 cell responses. J Gen Virol (1998) 1.16
IL-15 induces type 1 and type 2 CD4+ and CD8+ T cells proliferation but is unable to drive cytokine production in the absence of TCR activation or IL-12 / IL-4 stimulation in vitro. Eur J Immunol (2002) 1.13
T-cell subsets in autoimmunity. Curr Opin Immunol (1992) 1.10
Nitric oxide inhibits the secretion of T-helper 1- and T-helper 2-associated cytokines in activated human T cells. Immunology (1997) 1.05
Septic arthritis following Staphylococcus aureus infection in mice lacking inducible nitric oxide synthase. J Immunol (1998) 0.99
Role of nitric oxide in autoimmunity. Clin Immunol Immunopathol (1995) 0.97
Co-stimulatory effect of nitric oxide on endothelial NF-kappaB implies a physiological self-amplifying mechanism. Eur J Immunol (1998) 0.95
Activation of cGMP-dependent protein kinase Ibeta inhibits interleukin 2 release and proliferation of T cell receptor-stimulated human peripheral T cells. J Biol Chem (2000) 0.94
Nitric oxide selectively decreases interferon-gamma expression by activated human T lymphocytes via a cGMP-independent mechanism. Immunology (1999) 0.83
Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells. Proc Natl Acad Sci U S A (2006) 3.70
IL-33 reduces the development of atherosclerosis. J Exp Med (2008) 3.59
IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J Immunol (2009) 3.41
MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc Natl Acad Sci U S A (2011) 3.37
IL-33, a potent inducer of adaptive immunity to intestinal nematodes. J Immunol (2008) 3.31
Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J Immunol (2002) 3.30
ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat Immunol (2004) 3.19
TLR2 is expressed on activated T cells as a costimulatory receptor. Proc Natl Acad Sci U S A (2004) 3.04
IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc Natl Acad Sci U S A (2008) 2.99
IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4. J Immunol (2008) 2.83
IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol (2007) 2.82
IL-33 is a chemoattractant for human Th2 cells. Eur J Immunol (2007) 2.43
Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nat Med (2010) 2.38
Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study. Arthritis Rheum (2005) 2.37
A novel anti-inflammatory role for simvastatin in inflammatory arthritis. J Immunol (2003) 2.37
CD4+CD25+ regulatory T cells cure murine colitis: the role of IL-10, TGF-beta, and CTLA4. J Immunol (2003) 2.19
Retracted The cytokine interleukin-33 mediates anaphylactic shock. Proc Natl Acad Sci U S A (2009) 2.15
CD4+CD25+ regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice. J Immunol (2003) 2.11
A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma. J Immunol (2004) 1.88
Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice. Circ Res (2010) 1.80
IL-33 exacerbates eosinophil-mediated airway inflammation. J Immunol (2010) 1.73
IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival. J Immunol (2011) 1.72
IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice. Proc Natl Acad Sci U S A (2008) 1.67
A novel therapeutic approach targeting articular inflammation using the filarial nematode-derived phosphorylcholine-containing glycoprotein ES-62. J Immunol (2003) 1.62
IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy. Ann Rheum Dis (2010) 1.62
Animal models of rheumatoid arthritis. Eur J Immunol (2009) 1.57
A novel therapy of murine collagen-induced arthritis with soluble T1/ST2. J Immunol (2004) 1.55
Type 2 innate lymphoid cells drive CD4+ Th2 cell responses. J Immunol (2014) 1.48
Nitric oxide induces CD4+CD25+ Foxp3 regulatory T cells from CD4+CD25 T cells via p53, IL-2, and OX40. Proc Natl Acad Sci U S A (2007) 1.45
A brief visual primer for the mapping of mortality trend data. Int J Health Geogr (2004) 1.44
IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages. Eur J Immunol (2012) 1.43
TLR2 agonist ameliorates established allergic airway inflammation by promoting Th1 response and not via regulatory T cells. J Immunol (2005) 1.41
IL-33 exacerbates autoantibody-induced arthritis. J Immunol (2010) 1.40
CXCR2-specific chemokines mediate leukotriene B4-dependent recruitment of neutrophils to inflamed joints in mice with antigen-induced arthritis. Arthritis Rheum (2008) 1.39
IL-33 reduces macrophage foam cell formation. J Immunol (2010) 1.32
Prostaglandin mediates IL-23/IL-17-induced neutrophil migration in inflammation by inhibiting IL-12 and IFNgamma production. Proc Natl Acad Sci U S A (2009) 1.31
Galectin-3 is a negative regulator of lipopolysaccharide-mediated inflammation. J Immunol (2008) 1.29
The IL-33/ST2 pathway--A new therapeutic target in cardiovascular disease. Pharmacol Ther (2011) 1.28
Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis. J Immunol (2009) 1.28
IL-18 enhances collagen-induced arthritis by recruiting neutrophils via TNF-alpha and leukotriene B4. J Immunol (2003) 1.26
Colony-stimulating factor-1 suppresses responses to CpG DNA and expression of toll-like receptor 9 but enhances responses to lipopolysaccharide in murine macrophages. J Immunol (2002) 1.23
Differential regulation of interleukin-12 p40 and p35 induction via Erk mitogen-activated protein kinase-dependent and -independent mechanisms and the implications for bioactive IL-12 and IL-23 responses. Immunology (2003) 1.23
Interleukin-18 plays a role in both the alum-induced T helper 2 response and the T helper 1 response induced by alum-adsorbed interleukin-12. Immunology (2003) 1.22
A novel dendritic cell-induced model of erosive inflammatory arthritis: distinct roles for dendritic cells in T cell activation and induction of local inflammation. J Immunol (2002) 1.22
IL-1beta-driven ST2L expression promotes maturation resistance in rapamycin-conditioned dendritic cells. J Immunol (2008) 1.22
Interleukin-33 and the function of innate lymphoid cells. Trends Immunol (2012) 1.20
Regulation of type 17 helper T-cell function by nitric oxide during inflammation. Proc Natl Acad Sci U S A (2011) 1.14
IL-15 induces type 1 and type 2 CD4+ and CD8+ T cells proliferation but is unable to drive cytokine production in the absence of TCR activation or IL-12 / IL-4 stimulation in vitro. Eur J Immunol (2002) 1.13
IL-35 over-expression increases apoptosis sensitivity and suppresses cell growth in human cancer cells. Biochem Biophys Res Commun (2012) 1.12
IL-33 shifts the balance from osteoclast to alternatively activated macrophage differentiation and protects from TNF-alpha-mediated bone loss. J Immunol (2011) 1.12
Retracted Expression and function of Toll-like receptor on T cells. Cell Immunol (2005) 1.12
IL-33 induces skin inflammation with mast cell and neutrophil activation. Eur J Immunol (2011) 1.11
Cytokine networks--towards new therapies for rheumatoid arthritis. Nat Clin Pract Rheumatol (2005) 1.11
IL-12, but not IL-18, is critical to neutrophil activation and resistance to polymicrobial sepsis induced by cecal ligation and puncture. J Immunol (2006) 1.08
Glucocorticoid-induced TNFR family-related protein (GITR) activation exacerbates murine asthma and collagen-induced arthritis. Eur J Immunol (2005) 1.08
Interleukin-33 exacerbates acute colitis via interleukin-4 in mice. Immunology (2013) 1.07
IL-23 promotes osteoclast formation by up-regulation of receptor activator of NF-kappaB (RANK) expression in myeloid precursor cells. Eur J Immunol (2008) 1.06
IL-15 mediates antigen-induced neutrophil migration by triggering IL-18 production. Eur J Immunol (2007) 1.06
ST2, an IL-1R family member, attenuates inflammation and lethality after intestinal ischemia and reperfusion. J Leukoc Biol (2006) 1.03
IL-15, a survival factor for kidney epithelial cells, counteracts apoptosis and inflammation during nephritis. J Clin Invest (2002) 1.03
Treatment with soluble interleukin-15Ralpha exacerbates intracellular parasitic infection by blocking the development of memory CD8+ T cell response. J Exp Med (2002) 1.02
Antigen-induced inflammatory mechanical hypernociception in mice is mediated by IL-18. Brain Behav Immun (2006) 1.02
IL-33 activates B1 cells and exacerbates contact sensitivity. J Immunol (2011) 1.01
Lipopolysaccharide-induced M2 to M1 macrophage transformation for IL-12p70 production is blocked by Candida albicans mediated up-regulation of EBI3 expression. PLoS One (2013) 1.00
Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1. J Immunol (2008) 0.99
IL-33 induces innate lymphoid cell-mediated airway inflammation by activating mammalian target of rapamycin. J Allergy Clin Immunol (2012) 0.98
IL-18 is a key proximal mediator of contact hypersensitivity and allergen-induced Langerhans cell migration in murine epidermis. J Leukoc Biol (2007) 0.98
Resveratrol modulates murine collagen-induced arthritis by inhibiting Th17 and B-cell function. Ann Rheum Dis (2011) 0.98
Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1. J Immunol (2008) 0.97
A TLR2 ligand suppresses inflammation by modulation of chemokine receptors and redirection of leukocyte migration. Blood (2009) 0.95
Interleukin-18 induces mechanical hypernociception in rats via endothelin acting on ETB receptors in a morphine-sensitive manner. J Pharmacol Exp Ther (2004) 0.95
Chemoattraction of human T cells by IL-18. J Immunol (2003) 0.95
Nitric oxide exerts distinct effects in local and systemic infections with Streptococcus pneumoniae. Microb Pathog (2004) 0.92
Interleukin-18: a therapeutic target in rheumatoid arthritis? Arthritis Res Ther (2004) 0.92
Role of bacterial lipopolysaccharide in enhancing host immune response to Candida albicans. Clin Dev Immunol (2013) 0.91
Nitric oxide-induced regulatory T cells inhibit Th17 but not Th1 cell differentiation and function. J Immunol (2013) 0.91
Expression and alternative processing of IL-18 in human neutrophils. Eur J Immunol (2006) 0.90
Direct and indirect role of Toll-like receptors in T cell mediated immunity. Cell Mol Immunol (2004) 0.90
Interactions of Candida albicans with host epithelial surfaces. J Oral Microbiol (2013) 0.90
IL-15 mediates immune inflammatory hypernociception by triggering a sequential release of IFN-gamma, endothelin, and prostaglandin. Proc Natl Acad Sci U S A (2006) 0.89
What can the periodontal community learn from the pathophysiology of rheumatoid arthritis? J Clin Periodontol (2011) 0.89
The IL-33/ST2 pathway controls coxsackievirus B5-induced experimental pancreatitis. J Immunol (2013) 0.88
Immunological mechanisms and clinical implications of regulatory T cell deficiency in a systemic autoimmune disorder: roles of IL-2 versus IL-15. Eur J Immunol (2008) 0.88
Interleukin-18 is regulated by parathyroid hormone and is required for its bone anabolic actions. J Biol Chem (2007) 0.87
The prevention of restenosis in vivo with a VEGF gene and paclitaxel co-eluting stent. Biomaterials (2012) 0.85
Oligoclonal expansions of antigen-specific CD8+ T cells in aged mice. Ann N Y Acad Sci (2003) 0.85
Role of IL-18 in overt pain-like behaviour in mice. Eur J Pharmacol (2008) 0.85
Interleukin-18 enhances a Th2 biased response and susceptibility to Leishmania mexicana in BALB/c mice. Microbes Infect (2008) 0.85
Effect of ingested interferon-alpha on beta-cell function in children with new-onset type 1 diabetes. Diabetes Care (2009) 0.84